Fusidic acid betamethasone lipid cream

Int J Clin Pract. 2016 May:70 Suppl 184:4-13. doi: 10.1111/ijcp.12808.

Abstract

Bacterial infections of the skin and soft tissues are frequent disorders. They can be primitive infections (e.g. impetigo, folliculitis) or secondary infections complicating other diseases, particularly atopic dermatitis. The most common aetiologic agent is Staphylococcus aureus. Topical antibiotic therapy may be sufficient in many instances to control these infections. Fusidic acid is an antibiotic used topically on the skin which is very active against S. aureus, including methicillin-resistant strains, and other Gram-positive bacteria. Resistance rates to fusidic acid are stably low. A fusidic acid and betamethasone formulation in a lipid-enriched cream (lipid cream) has been recently developed in order to provide effective antibacterial and anti-inflammatory activities in conjunction with a powerful emollient and moisturising effect. This preparation may be especially useful in patients with atopic-infected eczema.

Publication types

  • Multicenter Study
  • Randomized Controlled Trial

MeSH terms

  • Administration, Cutaneous
  • Anti-Bacterial Agents / administration & dosage*
  • Anti-Inflammatory Agents / administration & dosage*
  • Betamethasone / administration & dosage*
  • Dermatitis, Atopic / drug therapy
  • Dermatologic Agents / administration & dosage*
  • Drug Combinations
  • Drug Delivery Systems
  • Fusidic Acid / administration & dosage*
  • Humans
  • Ointments
  • Risk Factors
  • Staphylococcal Skin Infections / drug therapy*
  • Staphylococcus aureus

Substances

  • Anti-Bacterial Agents
  • Anti-Inflammatory Agents
  • Dermatologic Agents
  • Drug Combinations
  • Ointments
  • Fusidic Acid
  • Betamethasone